Barton Medical Limited

	Registered number
	06078803

	Barton Medical Limited
	Unaudited Accounts
	for the year ended
	31 March 2025

Barton Medical Limited Balance Sheet as at 31 March 2025
	Notes		2025 £		2024 £
Current assets
Debtors		20,207		18,711
Cash at bank and in hand		10,860		5,312
		31,067		24,023

Creditors: amounts falling due within one year		(8,252)		(1,776)

Net current assets / (liabilities)			22,815		22,247

Total assets less current liabilities			22,815		22,247

Provisions for liabilities			(0)		(0)

Total net assets (liabilities)			22,815		22,247

Capital and reserves
Called up share capital	3		201		201
Profit and loss account			22,614		22,046
Shareholders' funds			22,815		22,247

These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr C Saggers

Director

Approved by the board on 3 December 2025

Company Number: 06078803 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

Well Cottage Cucumber Lane
Essendon
Hatfield
AL9 6JB
England

1.	Accounting policies
	Basis of preparation of financial statements These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.

	Revenue recognition
	Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when goods are delivered and legal title has passed.

Employees
	2025	2024
Average number of employees during the period	0	0

Share capital
	2025	2024
	£	£
Allotted, called up and fully paid:
101 (2024: 101) A Ordinary shares of £1.00 each	101	101

Allotted, called up and fully paid:
100 (2024: 100) B Ordinary shares of £1.00 each	100	100

	201	201

	Commitments, guarantees and contingencies
	Notes Capital pension lease and other financial commitments, guarantees and contingencies The company had no capital, pension, lease or other financial commitments, guarantees and contingencies at the 31 March 2025 (2024 - None).

Commitments, guarantees and contingencies

Notes

Capital pension lease and other financial commitments, guarantees and contingencies The company had no capital, pension, lease or other financial commitments, guarantees and contingencies at the 31 March 2025 (2024 - None).

5.	Other information
	Barton Medical Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is Well Cottage, Cucumber Lane, Essendon, Hertfordshire AL9 6JB. The financial statements are presented in Sterling, which is the functional currency of the company. For the two years ending on the 31 March 2025 Christopher J. Saggers, the sole director of the company, controlled the company. The principal activity of the company in the year under review was the direct distribution of capital medical equipment and related consultancy.

Other information

Barton Medical Limited is a private company limited by shares and incorporated in England and Wales.
Its registered office is Well Cottage, Cucumber Lane, Essendon, Hertfordshire AL9 6JB.

The financial statements are presented in Sterling, which is the functional currency of the company.

For the two years ending on the 31 March 2025 Christopher J. Saggers, the sole director of the company, controlled the company.

The principal activity of the company in the year under review was the direct distribution of capital medical equipment and related consultancy.